L Wang, T Zhou, Y Zhang, ES Yang… - … (New York, NY), 2021 - pubmed.ncbi.nlm.nih.gov
The emergence of highly transmissible SARS-CoV-2 variants of concern (VOCs) that are resistant to therapeutic antibodies highlights the need for continuing discovery of broadly …
L Wang, T Zhou, Y Zhang, ES Yang, CA Schramm… - Science (New York … - ncbi.nlm.nih.gov
RESULTS: Blood from 22 convalescent subjects who recovered from SARS-CoV-2 WA-1 infection was screened for neutralizing and binding activity, and four subjects with high …
L Wangºf, T Zhou, Y Zhang, ES Yang, CA Schramm… - scholar.archive.org
The emergence of highly transmissible SARS-CoV-2 variants of concern (VOC) that are resistant to therapeutic antibodies highlights the need for continuing discovery of broadly …
L Wang, T Zhou, Y Zhang, ES Yang, CA Schramm… - Science, 2021 - cir.nii.ac.jp
抄録< jats: title> Defenses against SARS-CoV-2 variants</jats: title>< jats: p> Our key defense against the COVID-19 pandemic is neutralizing antibodies against the SARS-CoV-2 …
L Wang, T Zhou, Y Zhang, ES Yang… - Science (New York …, 2021 - europepmc.org
RESULTS: Blood from 22 convalescent subjects who recovered from SARS-CoV-2 WA-1 infection was screened for neutralizing and binding activity, and four subjects with high …
L Wang, T Zhou, Y Zhang, ES Yang, CA Schramm… - Science, 2021 - cdr.lib.unc.edu
Abstract IC80 1.5 to 34.5 nanograms per milliliter). We define the structural and functional determinants of binding for all four VOC-targeting antibodies and show that combinations of …
L Wang, T Zhou, Y Zhang, ES Yang… - … (New York, NY), 2021 - pubmed.ncbi.nlm.nih.gov
The emergence of highly transmissible SARS-CoV-2 variants of concern (VOCs) that are resistant to therapeutic antibodies highlights the need for continuing discovery of broadly …